PFE
Pfizer Inc.
$27.47
$0.00(0.00%)
65
Overall
100
Value
50
Tech
47
Quality
Market Cap
$154.15B
Volume
33.77M
52W Range
$20.92 - $28.75
Target Price
$28.98
Company Overview
| Mkt Cap | $154.15B | Price | $27.47 |
| Volume | 33.77M | Change | +0.00% |
| P/E Ratio | 19.2 | Open | $27.25 |
| Revenue | $63.6B | Prev Close | $27.47 |
| Net Income | $8.0B | 52W Range | $20.92 - $28.75 |
| Div Yield | 1.72% | Target | $28.98 |
| Overall | 65 | Value | 100 |
| Quality | 47 | Technical | 50 |
No chart data available
Latest News
Pfizer’s New Phase 1 PF-07328948 Study Signals Ongoing Pipeline Investment
TipRanks Clinical-Trials-Auto-Generated Newsdesk•2 days ago
Pfizer Targets Advanced Kidney Cancer With New PF-08634404 Trial: What Investors Should Know
TipRanks Clinical-Trials-Auto-Generated Newsdesk•2 days ago
Pfizer’s New Phase 1 PF-07328948 Study Signals Ongoing Pipeline Investment
TipRanks Clinical-Trials-Auto-Generated Newsdesk•2 days ago
Pfizer Targets Advanced Kidney Cancer With New PF-08634404 Trial: What Investors Should Know
TipRanks Clinical-Trials-Auto-Generated Newsdesk•2 days ago
RBC Capital Reaffirms Their Sell Rating on Pfizer (PFE)
TipRanks Auto-Generated Intelligence Newsdesk•2 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PFE | $27.47 | 0% | 33.77M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |